|
Ken Tindall came to the Biotechnology Center from the National Institute of Environmental Health Sciences, where he was a tenured geneticist and head of the Molecular Mutagenesis Group. He oversees the Biotechnology Center's Business and Technology, Education & Training and Science & Technology programs. He is also the president of the Center-sponsored North Carolina Genomics and Bioinformatics Consortium. Tindall is also an adjunct professor in the Curriculum in Toxicology at the University of North Carolina at Chapel Hill.
Tindall has more than 20 years of experience in the field of mutagenesis, focusing on the mechanisms by which mutations contribute to genomic instability, leading to genetic dysfunctions associated with cancer and human genetic disease. He earned his bachelor's degree in biology and master's degree in biochemistry from Montana State University. He obtained his doctoral degree in genetics from the University of Tennessee at Oak Ridge. | 